SCHEMBL2031950

SCHEMBL2031950

CN(C)/C=N\c1nc(O/N=C/c2ccccc2)ncc1F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.33
ALDH1A1 P00352 5/20 0.33
GLA P06280 2/20 0.33
GAA P10253 2/20 0.33
MAPT P10636 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HTT P42858 2/20 0.31
LMNA P02545 2/20 0.31
HSD17B10 Q99714 2/20 0.31
ALOX15 P16050 1/20 0.31
MAPK1 P28482 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
USP2 O75604 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12585920 1.00 KDM4E (0.33) KDM4EALDH1A1GLAGAAMAPT
SCHEMBL2031951 1.00 KDM4E (0.33) KDM4EALDH1A1GLAGAAMAPT
SCHEMBL12514917 0.89 GAA (0.33) KDM4EALDH1A1GAAMAPTMEN1
SCHEMBL16304014 0.88 MAPT (0.38) KDM4EALDH1A1GLAGAAMAPT
SCHEMBL12585943 0.88 MAPT (0.38) KDM4EALDH1A1GLAGAAMAPT
SCHEMBL2033047 0.87 ALDH1A1 (0.36) KDM4EALDH1A1GAAMAPTCYP1A2
SCHEMBL2033045 0.87 ALDH1A1 (0.36) KDM4EALDH1A1GAAMAPTCYP1A2
SCHEMBL12585937 0.87 ALDH1A1 (0.36) KDM4EALDH1A1GAAMAPTCYP1A2
SCHEMBL12515461 0.84 L3MBTL1 (0.35) KDM4EALDH1A1GLAGAAMAPT
SCHEMBL12514910 0.83 NFE2L2 (0.36) KDM4EALDH1A1GAAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8912207-B2 2-aldoximino-5-fluoropyrimidine derivatives Dow AgroSciences, LLP. (US) 2014-12-16 US disclosed
EP-2512482-A1 2-ALDOXIMINO-5-FLUOROPYRIMIDINE DERIVATIVES Dow AgroSciences LLC (US) 2012-10-24 EP disclosed
WO-2011084611-A1 2-ALDOXIMINO-5-FLUOROPYRIMIDINE DERIVATIVES DOW AGROSCIENCES LLC (US) 2011-07-14 WO disclosed
US-20110152300-A1 2-ALDOXIMINO-5-FLUOROPYRIMIDINE DERIVATIVES DOW AGROSCIENCES LLC 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152300-A1 2-ALDOXIMINO-5-FLUOROPYRIMIDINE DERIVATIVES AKR7A2, DPYD, DPM1 KDM4E 1647/4885ALDH1A1 25/4885GLA 3956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.